Position in VRDN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,146,144
-$27,946,776 QoQ
Shares Held
927,717
-37.4% QoQ
Ownership
0.900%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOOMIS SAYLES & CO L P holds $4,075,180,510 across 25 Biotechnology names. VRDN ranks #20 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,003,821 | $1,787,866,229 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,912,310 | $1,477,527,197 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
512,097 | $169,437,533 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
353,209 | $70,518,176 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
968,135 | $46,054,181 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
475,324 | $43,910,430 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
256,625 | $43,374,756 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
465,102 | $40,449,920 |
All Filings in VRDN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,146,144 | 927,717 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $46,092,920 | 1,481,135 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $33,456,077 | 1,550,328 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,711,838 | 1,338,472 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $18,472,398 | 1,370,356 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $26,845,303 | 1,400,381 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||